ClinVar Miner

Submissions for variant NM_005732.4(RAD50):c.1246-2A>G

dbSNP: rs1580993323
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001010532 SCV001170748 uncertain significance Hereditary cancer-predisposing syndrome 2019-08-27 criteria provided, single submitter clinical testing The c.1246-2A>G intronic variant results from an A to G substitution two nucleotides upstream from coding exon 9 in the RAD50 gene. This nucleotide position is highly conserved in available vertebrate species. Using the Human Splicing Finder (HSF) splice site prediction tool, this alteration is predicted to abolish the weakly predicted native splice acceptor; however, direct evidence is unavailable (Desmet FO et al. Nucleic Acids Res. 2009 May;37:e67). In addition, the BDGP and ESEfinder in silico splicing models do not produce a reliable prediction for this splice acceptor site, therefore the predicted impact of this alteration on splicing cannot be determined at this time. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.